Louis M. Staudt
0000-0002-1735-2892
Publication & Citation Trends
Publications
800 total
Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma
Cited by 1
Semantic Scholar
Motive and Opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements-an LLMPP study.
Cited by 21
Semantic Scholar
Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells OA
Cited by 10
Semantic Scholar
Abstract 3913: Molecular mechanism of action and targets of glucocorticoids in lymphoma therapy
Cited by 0
Semantic Scholar
Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition
Cited by 1
Semantic Scholar
Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients. OA
Cited by 40
Semantic Scholar
Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy. OA
Cited by 19
Semantic Scholar
Blimp-1 is a negative regulator of IL-2 signaling in T cells OA
Cited by 0
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(422)
Chronic Lymphocytic Leukemia Research
(204)
CAR-T cell therapy research
(119)
Monoclonal and Polyclonal Antibodies Research
(100)
Immune Cell Function and Interaction
(76)
Affiliations
The Wistar Institute
Human Genome Sciences (United States)
Ontario Institute for Cancer Research
University of North Carolina at Chapel Hill
University of Southern California